StonvexLoading…
StonvexStonvexStonvexCore line items from BCHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.24M | $17.63M | $13.84M | $6.47M |
Operating Income | $-1.15M | $-3.03M | $-1.72M | $-2.53M |
Net Income | $-1.35M | $-3.03M | $-2.43M | $-1.54M |
EPS (Diluted) | $-0.06 | $-0.16 | $-0.03 | $-0.03 |
Total Assets | $21.40M | $9.24M | $10.14M | $8.57M |
Total Liabilities | $10.23M | $10.95M | $11.28M | $10.52M |
Cash & Equivalents | $14.75M | $2.25M | $1.77M | $1.45M |
Free Cash Flow OCF − CapEx | $-2.21M | $-729.41K | $-1.69M | $-2.00M |
Shares Outstanding | 26.31M | 19.46M | 96.87M | 96.87M |